Here are seven additional notes on the report:
- 2024 second quarter revenue was slightly higher than the $1.38 billion recorded in the second quarter of 2023.
- Revenue in the first half of 2024 totaled $2.83 billion, up 3.4% from the first half of 2023.
- The company’s operating profit in the first half of 2024 was $328 million.
- Orthopedics revenue in the second quarter increased 5.8%, with growth in hip and knee implants outside of the U.S.
- Smith+Nephew’s sports medicine, and ear, nose and throat sector increased 7.6% in the second quarter of 2024.
- Trading profit increased 12.8% in the first half of 2024 and is up to $471 million.
- The company expects 2024 underlying revenue growth to be between 5% and 6%.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
